Hypercell Technologies
Hypercell Technologies reported $2,958,378 raised in an SEC Form D filed on 2026-10-14. State of the filing: New York.
- Industry
- Biotechnology
- Location
- New York
About
Hypercell Technologies appears in Section 3 of the Raise Track Update of 2026-10-15, which lists new SEC Form D filings. The filing reports $2,958,378 raised and gives New York as the state. The industry on the filing is Biotechnology. Related persons named on the filing: Bruno Jactel (executive officer, director, Ithaca, New York); Loic DeBlais (executive officer, Ithaca, New York); Samuel Jactel (executive officer, director, Ithaca, New York); James Cali (director, Ithaca, New York); Tony Puri (director, Ithaca, New York). Filing: https://www.sec.gov/Archives/edgar/data/1882357/000188235726000004/0001882357-26-000004-index.htm
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-10-14 | $2.96M |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/1882357/000188235726000004/0001882357-26-000004-index.htm
Type: sec filing. Accessed 2026-10-15.
SEC Form D for Hypercell Technologies Inc. EDGAR filing date 2026-10-14. Signed 2026-10-14. First sale 2026-09-08. Total amount sold $2,958,378 of an offering amount of $4,423,378. 14 investors already invested. Issuer address city is Ithaca, New York. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. The form gives a related person's name as Bruno Georges Jactel. The page uses Bruno Jactel. The EDGAR filing index lists a business address in Brookhaven, Georgia. The issuer address on primary_doc.xml is Ithaca, New York, which matches the Raise Track Update. The page uses New York. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
Type: other verified public source. Accessed 2026-10-15.
Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Hypercell Technologies, state NEW YORK, industry Biotechnology, amount raised $2,958,378.